Diarylsulfones as 5-HT2A antagonists

Details for Australian Patent Application No. 2005276233 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Hunt, Peter Alan; Merchant, Kevin John; Gilligan, Myra; Humphries, Alexander Charles; Macleod, Angus Murray; Cooper, Laura Catherine; Van Niel, Monique Bodil; Wilson, Kevin; Castro Pineiro, Jose Luis; Ladduwahetty, Tamara

Agent Spruson & Ferguson

Pub. Number AU-B-2005276233

PCT Pub. Number WO2006/021805

Priority 0419192.0 27.08.04 GB

Filing date 26 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 17 March 2011

International Classifications

C07C 317/44 (2006.01) Sulfones

C07C 317/14 (2006.01) Sulfones

C07C 317/22 (2006.01) Sulfones

C07C 317/24 (2006.01) Sulfones

C07C 317/28 (2006.01) Sulfones

C07C 317/32 (2006.01) Sulfones

C07C 317/36 (2006.01) Sulfones

C07C 317/42 (2006.01) Sulfones

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 207/10 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/72 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/34 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 217/24 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 261/08 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/26 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/096 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/021805 Priority application(s): WO2006/021805

17 March 2011 Application Accepted

  Published as AU-B-2005276233

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005276238-Methods and compositions relating to Alzheimer's disease

2005276232-A diaphragm and a diaphragm pump